Baclofen for the Treatment of Cocaine Dependence - 1

Completed · Phase 2 · Has a placebo group

Conditions studied: Cocaine-Related Disorders

In brief

The purpose of this study is to assess the efficacy and safety of baclofen for the treatment of cocaine dependence.

Key facts

Study ID

NCT00082485

Run by

National Institute on Drug Abuse (NIDA)

People needed

160

Starts

2004-06-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject must have DSM-IV diagnosis of cocaine dependence.
• Subject must be seeking treatment for cocaine dependence.
• Be be able to verbalize understanding of consent form, provide written consent and verbalize willingness to complete study procedures.

You may not qualify if…

• Please contact site for more information.

Where it is running

• San Francisco General Hosptial — San Francisco, California, United States
• Torrance Site — Torrance, California, United States
• Denver VA Medical Center — Denver, Colorado, United States
• VA Maryland Healthcare System — Baltimore, Maryland, United States
• U of Penn School of Medicine — Philadelphia, Pennsylvania, United States
• South TX VA Health Care System — San Antonio, Texas, United States
• Salt Lake City VA Medical Center — Salt Lake City, Utah, United States
• Institute of Resch & Educ Inova Fairfax Hospital — Falls Church, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.